Exact Mass: 296.0864

Exact Mass Matches: 296.0864

Found 159 metabolites which its exact mass value is equals to given mass value 296.0864, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2,3,9,10-Tetrahydroxyberberine

C17H14NO4+ (296.0923)

Dehypoxanthine futalosine

3-[3-(3,4,5-Trihydroxytetrahydrofuran-2-yl)propionyl]benzoic acid

C14H16O7 (296.0896)

3,3-DIMETHOXYBENZIDINE-4,4-DIISOCYANATE

1,1-Biphenyl,4,4-diisocyanato-3,3-dimethoxy-

C16H12N2O4 (296.0797)

5,5',6,6'-Tetrahydroxy-3,3'-biindolyl

3-(5,6-Dihydroxy-1H-indol-3-yl)-1H-indole-5,6-diol

C16H12N2O4 (296.0797)

3,3-Bi-1H-indole-5,5,6,6-tetrol is found in root vegetables. 3,3-Bi-1H-indole-5,5,6,6-tetrol is a constituent of beetroot peel, Beta vulgaris. A polyphenol compound found in foods of plant origin (PhenolExplorer).

5-Hydroxy-4-methoxy-3-methyl-2,6-canthinedione

3-hydroxy-4-methoxy-6-methyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5(16),8,10,12,14-hexaene-2,7-dione

C16H12N2O4 (296.0797)

5-Hydroxy-4-methoxy-3-methyl-2,6-canthinedione is an alkaloid from the wood of Quassia amara (Surinam quassia).

4-Carboxynevirapine

2-cyclopropyl-10-oxo-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-7-carboxylic acid

C15H12N4O3 (296.0909)

4-Carboxynevirapine is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia)

Phenytoin methylcatechol

5-(2,5-dioxo-4-phenylimidazolidin-4-yl)-2-hydroxybenzaldehyde

C16H12N2O4 (296.0797)

Phenytoin methylcatechol is a metabolite of phenytoin. Phenytoin sodium is a commonly used antiepileptic. Phenytoin acts to suppress the abnormal brain activity seen in seizure by reducing electrical conductance among brain cells by stabilizing the inactive state of voltage-gated sodium channels. Aside from seizures, it is an option in the treatment of trigeminal neuralgia in the event that carbamazepine or other first-line treatment seems inappropriate. It is sometimes considered a class 1b antiarrhythmic. (Wikipedia)

Penicillamine disulfide

2-amino-3-[(1-amino-1-carboxy-2-methylpropan-2-yl)disulfanyl]-3-methylbutanoic acid

C10H20N2O4S2 (296.0864)

Flunixin

2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid

C14H11F3N2O2 (296.0773)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D058633 - Antipyretics

Paracetamol mercapturate

4-acetamidophenyl 2-acetamido-3-sulfanylpropanoate

C13H16N2O4S (296.0831)

Taltrimide

2-(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-(propan-2-yl)ethane-1-sulphonamide

C13H16N2O4S (296.0831)

C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

rhamnetin 3-rhamninoside

(1E,5R,6S,7S)-5,6,7,8-tetrahydroxy-1-(4-hydroxyphenyl)oct-1-ene-3,4-dione

C14H16O7 (296.0896)

(1S,2R,4R,5R,6R,8R)-4-bromo-2,5,6-trimethyl-11-methylenetricyclo<6.2.1.01,6>undecan-3-one|(1S,2R,4R,5R,6R,8R)-4-bromo-2,5,6-trimethyl-11-methylenetricyclo[6.2.1.01,6]undecan-3-one

(1S*,2R*,4R*,5R*,6R*,8R*)-4-bromo-2,5,6-trimethyl-11-methylenetricyclo<6.2.1.01,6>undecan-3-one|(1S*,2R*,4R*,5R*,6R*,8R*)-4-bromo-2,5,6-trimethyl-11-methylenetricyclo[6.2.1.01,6]undecan-3-one

C15H21BrO (296.0776)

4-episawaranin

C14H16O7 (296.0896)

1-(1-chloroethyl)-4-oxocyclopent-2-enyl 3-(3-oxocyclopent-1-enyl)propanoate|trichodermone B

C15H17ClO4 (296.0815)

delesserine

C14H16O7 (296.0896)

Chloticol

C15H17ClO4 (296.0815)

plumeridoid A

C14H16O7 (296.0896)

okamurene B

C15H21BrO (296.0776)

rugethanoid C

C14H16O7 (296.0896)

(+)-methyl 3-acetoxy-3-(7-methoxy-1,3-benzodioxol-5-yl)propanoate

C14H16O7 (296.0896)

5-O-trans-p-coumaroyl-L-arabinofuranose

C14H16O7 (296.0896)

(rel-1S,2R,6R,8S,9R)-8-bromo-2,5,6,9-tetramethyltricyclo[7.2.0.01,6]undec-4-en-3-one

C15H21BrO (296.0776)

1,6-Diacetoxyphenazine

C16H12N2O4 (296.0797)

5,7-dimethoxy-6-(1,2,3-trihydroxypropyl)-2H-1-benzopyran-2-one

C14H16O7 (296.0896)

Dimethyl Phenazine-1,6-dicarboxylate

C16H12N2O4 (296.0797)

1,9-Phenazinediyl diacetate

C16H12N2O4 (296.0797)

6-(2-Hydroxy-3-methyl-3-chlorobutyl)-7-methoxy-2H-1-benzopyran-2-one

C15H17ClO4 (296.0815)

aquilarin A

C14H16O7 (296.0896)

C14H16O7

C14H16O7 (296.0896)

(-)-4-(E)-caffeoyl-L-threonic acid

C14H16O7 (296.0896)

Flunixine

Flunixin Meglumine

C14H11F3N2O2 (296.0773)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3685 D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D058633 - Antipyretics

OCP_297.1002_16.5

C14H17ClN2O3 (296.0928)

CONFIDENCE Identification confirmed with Reference Standard (Level 1); INTERNAL_ID 1302

Penicillamine disulfide

C10H20N2O4S2 (296.0864)

(-)-Obtusadiene

(-)-10beta-bormo-1,3,7(14)-chamigratrien-9alpha-ol

C15H21BrO (296.0776)

5,5',6,6'-Tetrahydroxy-3,3'-biindolyl

3-(5,6-Dihydroxy-1H-indol-3-yl)-1H-indole-5,6-diol

C16H12N2O4 (296.0797)

5-Hydroxy-4-methoxy-3-methyl-2,6-canthinedione

3-hydroxy-4-methoxy-6-methyl-1,6-diazatetracyclo[7.6.1.0^{5,16}.0^{10,15}]hexadeca-3,5(16),8,10,12,14-hexaene-2,7-dione

C16H12N2O4 (296.0797)

(-)-Obtusadiene

(-)-10beta-bromo-1,3,7(14)-chamigratrien-9alpha-ol

C15H21OBr (296.0776)

Isoobtusadiene

C15H21OBr (296.0776)

dibutyldimethoxytin

C10H24O2Sn (296.0798)

(R)-1-(3-(6-(TRIFLUOROMETHYL)-1H-BENZO[D]IMIDAZOL-2-YL)ISOXAZOL-5-YL)ETHANAMINE

C13H11F3N4O (296.0885)

5-(4,4-DIMETHYL-2-OXO-2,4-DIHYDRO-1H-BENZO[D][1,3]OXAZIN-6-YL)-2-FLUOROBENZONITRILE

C17H13FN2O2 (296.0961)

dikegulac sodium

C12H17NaO7 (296.0872)

2-((3-(Trifluoromethyl)phenoxy)methyl)phenylboronic acid

C14H12BF3O3 (296.0832)

4-(3-(TRIFLUOROMETHYL)PHENOXYMETHYL)PH&

C14H12BF3O3 (296.0832)

1-BENZYL-1,2,3,4-TETRAHYDRO-QUINOXALINE DIHYDROCHLORIDE

C15H18Cl2N2 (296.0847)

2-Benzyloxy-5-(trifluoromethyl)phenylboronic acid

C14H12BF3O3 (296.0832)

2-(3-methoxycarbonylphenyl)-3H-benzimidazole-5-carboxylic acid

C16H12N2O4 (296.0797)

(4-(BENZYLOXY)-2-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID

C14H12BF3O3 (296.0832)

1-butyl-3-vinylimidazolium hexafluorophosphate

C9H15F6N2P (296.0877)

2,4-DIOXO-4-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRIC ACID METHYL ESTER

C14H16O7 (296.0896)

Thiothiamine

C12H16N4OS2 (296.0765)

4-Bromononanophenone

C15H21BrO (296.0776)

sodium,2-hydroxypropyl prop-2-enoate,prop-2-enoate,prop-2-enoic acid

C12H17NaO7 (296.0872)

3-(3-(TRIFLUOROMETHYL)PHENOXYMETHYL)PH&

C14H12BF3O3 (296.0832)

4-bromo-2-((cyclohexyl(methyl)amino)methyl)aniline

C14H21BrN2 (296.0888)

tris(1,2-diaminoethane) cobalt(iii) nitrate

C6H19CoN7O3+++ (296.0881)

[4-[(3-fluorophenyl)methyl]morpholin-2-yl]methanamine,dihydrochloride

C12H19Cl2FN2O (296.0858)

Ethyl 4-[2-(methylsulfonyl)ethyl]-1H-pyrrolo[2,3-b]pyridine-2-car boxylate

C13H16N2O4S (296.0831)

(4-(Benzyloxy)-3-(trifluoromethyl)phenyl)boronic acid

C14H12BF3O3 (296.0832)

Cystine diethyl ester

C10H20N2O4S2 (296.0864)

3-(4,4-DIMETHYL-2-OXO-2,4-DIHYDRO-1H-BENZO[D][1,3]OXAZIN-6-YL)-5-FLUOROBENZONITRILE

C17H13FN2O2 (296.0961)

1-[1-(4-Bromophenyl)ethyl]-4-ethylpiperazine

C14H21BrN2 (296.0888)

4,5-Dihydro-alpha,alpha,3-trimethyl-5-oxo-1-phenyl-1H-pyrazole-4-methanesulfonic acid

C13H16N2O4S (296.0831)

1-Benzyl-2,3-dihydro-1H-indol-6-ylamine dihydrochloride

C15H18Cl2N2 (296.0847)

N-[4-[(4-nitrophenyl)diazenyl]phenyl]prop-2-enamide

C15H12N4O3 (296.0909)

methyl 5-nitro-3-phenyl-1H-indole-2-carboxylate

C16H12N2O4 (296.0797)

dikegulac-sodium

C12H17NaO7 (296.0872)

RARECHEM AL BK 0816

C16H12N2O4 (296.0797)

5-Deoxy-5-(methylthio)-tubercidin

C12H16N4O3S (296.0943)

2-(5,6-dihydroxy-1H-indol-2-yl)-1H-indole-5,6-diol

C16H12N2O4 (296.0797)

4-Carboxy nevirapine

C15H12N4O3 (296.0909)

N-(1,3-dioxo-5-isoindolyl)-3-methoxybenzamide

C16H12N2O4 (296.0797)

4-(4-(2-Chlorophenyl)-1-piperazinyl)-4-oxobutanoic acid

C14H17ClN2O3 (296.0928)

7-(Aminomethyl)-6-(2-Chlorophenyl)-1-Methyl-1h-Benzimidazole-5-Carbonitrile

C16H13ClN4 (296.0829)

rhamnetin 3-rhamninoside

(1E,5R,6S,7S)-5,6,7,8-tetrahydroxy-1-(4-hydroxyphenyl)oct-1-ene-3,4-dione

C14H16O7 (296.0896)

N~2~-Acetyl-N~5~-(Phosphonoacetyl)-L-Ornithine

C9H17N2O7P (296.0773)

2-(5,6-dihydroxy-1H-indol-4-yl)-1H-indole-5,6-diol

C16H12N2O4 (296.0797)

2-(5,6-dihydroxy-1H-indol-7-yl)-1H-indole-5,6-diol

C16H12N2O4 (296.0797)

3-[3-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]propanoyl]benzoic acid

C14H16O7 (296.0896)

D-Penicillamine disulfide

C10H20N2O4S2 (296.0864)

4-(4-Phenylphenoxy)benzene-1,2-dicarbonitrile

C20H12N2O (296.095)

4-[5-(3-Methoxyphenyl)-1,2,4-oxadiazol-3-yl]benzoic acid

C16H12N2O4 (296.0797)

4-[5-(2-Methoxyphenyl)-1,2,4-oxadiazol-3-yl]benzoic acid

C16H12N2O4 (296.0797)

4-[5-(4-Methoxyphenyl)-1,2,4-oxadiazol-3-yl]benzoic acid

C16H12N2O4 (296.0797)

4-Methyl-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]quinolin-2-amine

C15H12N4O3 (296.0909)

6-(4-Ethenylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H16O7 (296.0896)

6-(3-Ethenylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H16O7 (296.0896)

3,4,5-Triacetoxybenzyl methyl ether

C14H16O7 (296.0896)

5,5,6,6-Tetrahydroxy-3,3-biindolyl

C16H12N2O4 (296.0797)

A hydroxyindole that is 1H-indole-5,6-diol substituted by a 5,6-dihydroxy-1H-indol-3-yl group at position 3.

Phenytoin methylcatechol

C16H12N2O4 (296.0797)

3,3'-Dithiodivaline

C10H20N2O4S2 (296.0864)

Dithiodivaline

C10H20N2O4S2 (296.0864)

TCS1105

C17H13FN2O2 (296.0961)

TCS1105 is a benzodiazepine ligand with agonist for α2-subunit containing GABAA receptors and antagonist for α1-subunit containing GABAA receptors. TCS1105 reduces anxiety-like behavior in mice. TCS1105 enhances offensive behavior and social dominance. TCS1105 blocks Sema3A induced AGC (axonal growth cones) collapse in a concentration-dependent fashion[1][2].